safety and efficacy of sparsentan to treat focal segmental glomerulosclerosis (fsgs)
Published 3 years ago • 1K plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
3:13
what is focal segmental glomerulosclerosis
-
5:44
focal segmental glomerulosclerosis - causes, symptoms, diagnosis, treatment, pathology
-
58:48
episode 4 - igan & fsgs series: management, treatment & recommendations for future research in fsgs
-
4:50
sparsentan promising for focal segmental glomerulosclerosis
-
4:07
focal segmental glomerulosclerosis, causes, signs and symptoms, diagnosis and treatment.
-
7:45
fsgs (focal segmental glomerulosclerosis) - mayo clinic
-
10:57
is proteinuria a good outcome measure for fsgs?
-
8:13
focal segmental glomerulosclerosis (fsgs) | nephrotic syndrome | 5-minute-review
-
1:29
brandon's patient story: focal segmental glomerulosclerosis (fsgs) diagnosis and treatment
-
3:21
sparsentan shows nephroprotective potential for treatment primary focal segmental glomerulosclerosis
-
1:11:28
clinical trial conference series: fsgs
-
5:20
old and new ways of understanding fsgs
-
1:01:23
targeting the podocyte as a treatment approach for fsgs
-
11:03
primary vs secondary focal segmental glomerulosclerosis
-
53:54
focal and segmental glomerulosclerosis is a lesion not a disease. prof. richard glassock,18 sep 2020
-
39:15
fsgs grand rounds
-
12:49
focal segmental glomerulosclerosis | fsgs | renal system | pathology | med vids made simple
-
1:00:39
episode 3 - igan & fsgs webinar series: pathophysiology & diagnosis of fsgs
-
13:32
focal segmental glomerulosclerosis (fsgs)